Levocetirizine Dihydrochloride + Montelukast
Indication:
Allergic rhinitis and allergic conditions such as asthma
Product Features
Form:
Chewable Tablets
Active Ingredient:
Levocetirizine Dihydrochloride + Montelukast
Active Ingredient Amount:
2.5 mg + 4 mg
Commercial Figure:
30 ve 90 adet çiğneme tableti içeren, Al/Al blister ve karton kutu ambalajlarda